The pharmaceutical pipeline is filled with promise
By ALICE PARK
Doctors are close to adding one more powerful ingredient to their
antiviral recipe against AIDS, Miraviroc (www.miraviroc). Researchers
at Pfizer have developed the first in a new class of compounds that
would prevent HIV from entering or infecting a healthy cell. So far,
the medications that have saved millions of AIDS patients around the
world have thwarted HIV at the end of its reproductive cycle;
Pfiezer's compound, a once a day pill called Miraviroc, targets the
beginning of the disease process. Now in the last stage of being tested
in patients, the compound, in combination with other anti-HIV drugs,
could become a significant roadblock in preventing HIV infections from
mushrooming into full-blown cases of AIDS.

Time Magazine
http://www.time.com/time/archive/preview/0,10987,1172235,00.html